📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Science Applications International Corporation provides technical, engineering, and mission and enterprise information technology (IT) services in the United States. It operates through two segments, Defense and Intelligence; and Civilian. The company offers IT modernization services for defense, intelligence, and civilian agencies; digital engineering services; artificial intelligence (AI) solutions; mission systems support and advisory; training and simulation; and ground vehicle support services for the nation’s armed forces. It also provides services for the design, development, integration, deployment, management and operations, sustainability, and security of IT infrastructure; mission IT solutions comprising CJADC2, data and AI, digital transformation, and quantum technologies; enterprise IT solutions consisting of service management, cloud, cybersecurity, and digital workplace; engineering services, including system integration and delivery services; and professional services, such as program management. The company serves military forces, including the Army, Air Force, Navy, Marines, Coast Guard, and Space Force; agencies of the Department of War, National Aeronautics and Space Administration, U.S. Department of State, Department of Justice, and Department of Homeland Security; and members of the Intelligence Community, as well as civilian markets, such as federal, state, and local governments. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding SAIC

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Jim Simons Renaissance Technologies LLC	92.5K	$8.8M	0.01%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Mixed ~ Volatile 4 quarters analysed

Q2 2026

Cautious

Management repeatedly used words like 'prudent', 'conservative', 'derisked', and 'challenging' to describe the near-term outlook. They emphasized that revenue headwinds are 'temporary' but simultaneously lowered guidance significantly and assumed 'little to no improvement' in on-contract growth or new business awards for the rest of FY26.

Q3 2026

Confident Specific

Management uses specific forward-looking numbers (e.g., $100 million in annual spend to reinvest, EBITDA margin guidance increase of 20 bps, $500 million annual buybacks) and cites concrete actions (organizational restructuring, SilverEdge integration). Language is direct: 'we are acting decisively', 'meaningful opportunities to further improve margins', 'strong program execution'. No hedging on key initiatives.

Q4 2026

Confident Specific

Management uses specific metrics (10% adjusted EBITDA margin guide, $600M FCF) and positive language like 'exceptional cash flow', 'strong execution', but acknowledges top-line contraction and recompete losses. They emphasize visible improvements in margins and cost discipline.

Q1 2027 latest

Mixed

Management expresses confidence in operational execution ('record margins', 'industry-leading cash flow') and early signs of growth, but repeatedly uses cautious language ('conservative hat', 'measured approach', 'uncertainties could impact remaining quarters', 'do not quarrel with the math but we have to go deliver'). They highlight upside while tempering expectations for the full year.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is incrementally stronger after this call. SAIC demonstrated record margins and strong cash flow, and management is taking deliberate steps to refocus the portfolio away from commoditized IT toward differentiated mission work. Organic growth returned modestly, and the guidance raise on EBITDA and EPS provides near-term confidence. However, the revenue guidance was not raised despite a better Q1, underscoring caution about the second half headwinds (RITS roll-off, uneven appropriations). The key watch items for next quarter are: (1) the timing and magnitude of the RITS revenue step-down, (2) progress on the Evolve recompete task orders, and (3) details from Project Orbit, which could unlock further margin expansion. If organic growth sustains and recompete win rates hit 90%, the stock's valuation could re-rate higher. The risk is that the civilian business margin spike proves unsustainable and that growth disappoints later in the year.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

🎙 Management Tone Mixed ~ Volatile 4 quarters Full tone analysis in Intelligence →

📊 MIXED SAIC Q1 FY2027 revenue $1.9B, adjusted EBITDA $222M, raises guidance

Revenue & Profitability

Q1 revenue was $1.9 billion with organic growth of 0.5%. Adjusted EBITDA was $222 million. Adjusted diluted EPS was $3.23. Free cash flow was $118 million. Net leverage stood at 3.1x. The company raised full-year adjusted EBITDA margin guidance to 10.1%-10.3% and adjusted EPS guidance to $9.90-$10.10, while maintaining free cash flow outlook of >$600 million.

Outlook

Management views the growth environment as improving but uneven. Appropriations from recent legislation are starting to flow, and another large FY2027 defense appropriation is expected. Recompete win rates are stabilizing toward 90%. However, uncertainty remains due to an election year and potential headwinds from recompete roll-offs (e.g., RITS).

Growth Drivers

Key growth drivers include on-contract growth (OCG) from new program ramps (targeting $500 million this year from $350 million last year), next-generation command and control, loitering munitions, and radar modernization. The Civilian segment delivered strong margin performance (15% in Q1). The Vanguard/Evolve recompete at State ($250M run rate, $10B ceiling) offers upside.

Balance Sheet & CapEx

CapEx specifics were not discussed, but management noted targeted investments in high-priority mission areas: advancing next-gen command and control, modernizing legacy radar capabilities, and establishing domestic production lines for loitering munitions and autonomous systems. Venture investments also support early-stage innovation.

Margins

Q1 adjusted EBITDA margin was a record, including a $12 million venture gain (60 bps). Full-year margin guidance was raised to 10.1%-10.3%. The Civilian segment achieved 15% margin. Management targets sustainable double-digit margins through disciplined bidding and cost efficiency. Project Orbit is expected to free up investment capacity to support further margin expansion.

Key Risks

Key risks include recompete headwinds (e.g., RITS $200M loss rolling off in Q3), uneven appropriations flow, environmental uncertainty due to election season, and potential insourcing at agencies like NASA. Management also flagged the need to regain shareholder trust through sustained organic growth.

Generated by AI · Q1 2027 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q1 2027 Q1 2027 2026-06-01

Fiscal Q1 2027 delivered record margins, strong cash flow, and 0.5% organic growth, driven by disciplined execution and portfolio realignment. Guidance was raised for EBITDA margin and EPS, with continued focus on high-value mission areas and operational efficiency.

Q4 2026 Q4 2026 2026-03-16

Leadership transition completed with a focus on operational excellence and portfolio alignment. FY26 revenue declined 3% organically, but margins and cash flow exceeded guidance. FY27 outlook anticipates continued revenue contraction due to recompete losses, but margin expansion and strong cash flow are expected.

Q3 2026 Q3 2026 2025-12-04

Q3 revenue declined 5.6% year-over-year but exceeded guidance after adjusting for shutdown impacts, with strong margins and free cash flow. The SilverEdge acquisition is expected to drive growth and margin expansion, while $1 billion in share repurchases is planned through FY27.

Q2 2026 Q2 2026 2025-09-04

Revenue declined 2.7% year-over-year amid program delays and government efficiency headwinds, but margins improved and book-to-bill remained strong. FY26 guidance was lowered, with cost efficiency measures underway and free cash flow outlook raised due to tax benefits.

Q1 2026 Q1 2026 2025-06-02

Q1 FY26 revenue grew 2% to $1.877B, with adjusted EBITDA margin at 8.4% and book-to-bill of 1.3. Guidance for FY26 is reiterated, targeting $7.6–$7.75B revenue, 9.4–9.6% EBITDA margin, and $9.10–$9.30 EPS. Civilian segment margins expanded, and backlog remains strong at ~$20B.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.